SCHEMBL4181326

SCHEMBL4181326

CCOc1ccc(/C=C(\C(N)=O)S(=O)(=O)Cc2ccc(Cl)cc2Cl)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.42
▸ MAPK1 P28482 2/20 0.41
▸ HDAC8 Q9BY41 1/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ MAPT P10636 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ S1PR4 O95977 1/20 0.40
▸ S1PR1 P21453 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ GPR35 Q9HC97 1/20 0.40
▸ FLT1 P17948 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4181331 1.00 LMNA (0.42) LMNAMAPK1HDAC8ALDH1A1MEN1
SCHEMBL4181334 1.00 LMNA (0.42) LMNAMAPK1HDAC8ALDH1A1MEN1
SCHEMBL4174013 0.87 TACR2 (0.47) LMNAMAPK1ALDH1A1MEN1KMT2A
SCHEMBL4175927 0.87 LMNA (0.41) LMNAHDAC8ALDH1A1MAPT
SCHEMBL4175932 0.87 LMNA (0.41) LMNAHDAC8ALDH1A1MAPT
SCHEMBL4175935 0.87 LMNA (0.41) LMNAHDAC8ALDH1A1MAPT
SCHEMBL4174021 0.87 TACR2 (0.47) LMNAMAPK1ALDH1A1MEN1KMT2A
SCHEMBL4174018 0.87 TACR2 (0.47) LMNAMAPK1ALDH1A1MEN1KMT2A
SCHEMBL4183039 0.83 ALDH1A1 (0.48) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL4183034 0.83 ALDH1A1 (0.48) LMNAALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 LMNA 4621/4885MAPK1 1909/4885HDAC8 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback